Joseph W Basler, M.D., PhD

Federal

Funding Agency NIH/NCI/Southwest Oncology Group Title A Phase III Blinded Study Of Immediate Post-TURBT Instillation Of Gemcitabine Versus Saline In Patients With Newly Diagnosed Or Occasionally Recurring Grade I/II Superficial Bladder Cancer (OCR #07-09) (SWOG S0337) Status Active Period 12/2007 - Present Role Co-Investigator Grant Detail   Funding Agency Center for Disease Control Title A Prospective Study on the Effect of Treatment on Health-Related Quality of Life for Men with Localized Prostate Cancer Status Active Period 9/2005 - Present Role Co-Investigator Grant Detail   Funding Agency NIH/NCI/EDRN/Johns Hopkins Univ/Univ. of Michigan Title EDRN PCA3 Validation Trial and Urinary Reference Set (Co-PI with Dr. Thompson as PI) Status Active Period 7/2009 - Present Role Co-Investigator Grant Detail   Funding Agency Veterans Administration Co-Operative Study Title Prostate Cancer Intervention Versus Observation Trial (PIVOT): A Randomized Trial Comparing Radical Prostatectomy Versus Palliative Expectant Management for the Treatment of Clinically Localized Prostate Cancer Status Active Period 8/2003 - Present Role Principal Investigator Grant Detail (study visits) (following 2 patients originally enrolled at other centers) Funding Agency NCI/UT MDACC Title A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride versus Placebo for Patients with Clinically Organ-Confined Prostate Cancer Status Active Period 1/2007 - Present Role Co-Investigator Grant Detail   Funding Agency Veteran's Health Administration Title Chemotherapy After Prostatectomy (CAP) for High Risk Prostate Carcinoma: A Phase III Randomized Study (CSP #553) Status Active Period 6/2008 - Present Role Co-Investigator Grant Detail  

Funding Agency UTHSCSA - Urology Title Establishment of a Data Base of Bladder Cancer in South Texas Status Active Period 2/2005 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - ERAHC Title Phase II Study to Assess the Activity of Nexrutine? in Prostate Cancer Patients Undergoing Surgery and Radiation Therapy Status Active Period 10/2010 - Present Role Co-Investigator Grant Detail Phase II Study to Assess the Activity of Nexrutine? in Prostate Cancer Patients Undergoing Surgery and Radiation Therapy Funding Agency UTHSCSA-Urology Title Establishment of a Data Base of Kidney Cancer in South Texas (Dr. Parekh?s study, you were Sub-I) Status Active Period 7/2007 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - PREF - Urology Title Identification of Protein and Genetic Biomarkers of Prostate Cancer and Risk Factors for Progression of Disease. Status Active Period 3/2002 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - Urology Title Biomarker Discovery for Renal Cell Carcinoma Through Serum, Urine and Tissue Protein Profiles Status Active Period 3/2004 - Present Role Co-Investigator Grant Detail   Funding Agency UTHSCSA - Urology Title Tissue Bank and Data Base for Urologic Diseases (Sub-I on GU TISSUE BANK protocol Dept of Pathology) Status Active Period 7/2000 - Present Role Co-Investigator Grant Detail